# Use of 2-Octyl Cyanoacrylate (Dermabond) in Neonatal Circumcision: A Randomized Controlled Trial

> **NCT04908137** · PHASE3 · UNKNOWN · sponsor: **The Hospital for Sick Children** · enrollment: 280 (estimated)

## Conditions studied

- Redundant Prepuce

## Interventions

- **DRUG:** 2-octyl cyanoacrylate

## Key facts

- **NCT ID:** NCT04908137
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-12-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908137, "Use of 2-Octyl Cyanoacrylate (Dermabond) in Neonatal Circumcision: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04908137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*